Hvsen Biotech (300871.SZ) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct27

Hvsen Biotech released FY2025 Q3 earnings on October 27 After-Market BJT, actual revenue CNY 437.33 M, actual EPS CNY 0.3495

01:00

Hvsen Biotech released FY2025 9 Months earnings on October 27 After-Market (BJT), actual revenue CNY 1.26 B, actual EPS CNY 0.9854

01:00

Oct20

Hvsen Biotech to Release FY2025 Q3 Earnings on October 28 After-Market (BJT)

01:09

Aug12

Huisheng Biology Increases Investment in Pet Medicine R&D and Market Channels

01:27

Aug7

Huisheng Bio's Pet Drug Enconazole Has Obtained Production License and Launched

01:31

Aug5

Huisheng Biotech Subsidiary Invests in Veterinary Drug Production Line Upgrades

10:49

Schedules & Filings

Schedules

Filings

Oct27

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 437.33 M, Net Income 70.72 M, EPS 0.3495

Aug26

Distribution Plan(CST)

Cash dividend 0.1 CNY

Distribution Plan(CST)

Cash dividend 0.1 CNY

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More